2021 U-M Kellogg Eye Center Annual Report

Page 18

Training Eye Disease Researchers in India Blindness and vision impairment combined are the number one cause of disability among India’s elderly — a growing segment

Kellogg professor David Musch, Ph.D., M.P.H., is the Pro-

of the country’s population. Both in India and in the U.S., poor

gram Director/Principal Investigator on the grant, and is joined

vision in old age is linked to increased risk of falls, dementia,

by co-investigator Joshua Ehrlich, M.D., M.P.H. “Kellogg and

depression, disability, loss of independence, longer and more Non-communicable disease accounts for more than nine in ten cases of vision loss in older Indians, and the majority of those cases are avoidable. The large and growing burden of preventable eye disease in India is compounded by a shortage of population health research expertise

the AECS have a long and productive history of close collaboration and educational exchanges,” Dr.

in the country — a critical barrier to developing effective, evidence-

Musch says. “This award reflects the shared commitment of Aravind and Kellogg to pursue research that will reduce and one day eliminate vision loss.” A needs assessment survey

SPECIAL EMPHASIS WILL BE PLACED

helped guide the development of the

ON THE TOOLS NEEDED TO CONDUCT

program’s curriculum. Post-grad-

LIFE-COURSE STUDIES, TO UNDERSTAND THE IMPACT OF VARIOUS EARLY- AND MID-LIFE

based interventions to stem the tide of vision-related disability.

frequent hospitalizations, and mortality.

EXPOSURES ON LATE-LIFE VISION.

The Kellogg Eye Center has pro-

— David Musch, Ph.D., M.P.H.

posed an ambitious training program to build clinical-epidemiological research capacity in India. The program is a partnership with the Aravind Eye Care System (AECS) located in southern India. AECS is the world’s largest

uate training tracks designed for early- and mid-career AECS faculty will establish a firm foundation in study design, research ethics and statistical analysis. “Special emphasis will be placed on the tools needed to conduct life-course studies,” explains Dr. Musch, “to understand the impact of various early- and mid-life exposures on

late-life vision.”

In addition to preparing India’s next generation

eye care system, and the training program leverages a diverse

of clinical-epidemiological eye researchers, the program will

array of research resources across the University of Michigan.

also bolster the mentoring and teaching skills of AECS faculty

The consortium has been awarded an International

leaders, in anticipation of all training activities transitioning to

Research Training Grant (D43) from the Fogarty International

David Musch, Ph.D., M.P.H., and Joshua Ehrlich, M.D., M.P.H.

16

Center of the National Institutes of Health (NIH).

AECS by the end of the 5-year grant period.

Aravind Srinivasan (Chief Medical Officer, Aravind Eye Hospital, Chennai, India) and Mr. Israel Gnanaraj (Hospital Architect)


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Toward a Therapeutic Target for Proliferative Vitreoretinopathy

2min
page 25

State-of-the-Science Microscope Gives Kellogg Researchers New Edge

2min
page 25

Michigan Medicine to Establish Neural Engineering Training Program

2min
page 21

Endocrine Society Award

1min
page 21

Leading on the National Stage

2min
page 15

Marshall Parks Lecture at AAO

1min
page 13

Prioritizing Communication for Patient Safety

2min
page 13

New Faculty Members

3min
page 42

Alumni Highlights

4min
page 39

Recognizing Distinguished Alumni Richard Gutow, M.D., and Gary Gutow, M.D.

6min
pages 36-37

Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases

2min
page 31

Big Data, Collaboration, and Impact

3min
page 35

A Visionary Legacy

3min
page 33

Eyes on the Future

3min
page 34

Kellogg’s Latest Heed Fellows

3min
page 32

U-M Learners Produce Online Newsletter

3min
page 29

Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels

3min
page 28

Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss

2min
page 30

Innovation in Action

3min
page 24

New Pediatric Ophthalmology Fellowship in Ghana

3min
page 27

Kellogg Addresses Technician Shortage with Ongoing Training Program

2min
page 26

Kellogg Researcher Launches First of-its-Kind Study of Health and Aging in Kenya

2min
page 23

A New Regulator of Retinal Angiogenesis Discovered

2min
page 22

Lipid Droplets May Protect Against AMD

2min
page 20

Mapping the Genetic Landscape of Nanophthalmos

2min
page 19

Training Eye Disease Researchers in India

2min
page 18

Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome

4min
pages 14-15

Clinical Research Update: Patient Perspectives

4min
page 17

Finding New Pathways for the Treatment of Choroideremia

2min
page 16

Finding a Personalized Solution for Dry Eye

3min
page 12

Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment

5min
pages 4-5

In it Together

5min
pages 10-11

Collaborating to Deliver Specialized Care

3min
pages 8-9

Steno North American Fellowship

2min
page 5

The Chair’s Perspective

2min
page 3

Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency

3min
page 7

COVID-19 Transmission Risk in Cornea Transplantation

2min
page 9

NIH-Funded Pilot Program Addresses Disparities in Glaucoma Care

3min
page 6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.